Current discoveries as well as research findings on various types of carbon nanostructures have inspired research into their utilization in a number of fields. These carbon nanostructures offer uses in pharmacy, medicine and different therapies. One such unique carbon nanostructure includes carbon nanotubes (CNTs), which are one-dimensional allotropes of carbon nanostructure that can have a length-to-diameter ratio greater than 1,000,000. After their discovery, CNTs have drawn extensive research attention due to their excellent material properties. Their physical, chemical and electronic properties are excellent and their composites provide great possibilities for enormous nanometer applications. The current study provides a systematic review based on prior literature review and data gathered from various sources. The various research studies from many research labs and organizations were systematically retrieved, collected, compiled and written. The entire collection and compilation of this review concluded the use of CNT approaches and their efficacy and safety for the treatment of various diseases such as brain tumors or cancer via nanotechnology-based drug delivery, phototherapy, gene therapy, antiviral therapy, antifungal therapy, antibacterial therapy and other biomedical applications. The current review covers diverse applications of CNTs in designing a range of targeted drug delivery systems and application for various therapies. It concludes with a discussion on how CNTs based medicines can expand in the future.

Nanotechnology is an escalating field that has made its contribution to all spheres of human life. The green synthesis of nanoparticles has paved for better methodologies and approaches in the medicinal field. Nowadays silver, gold and other metallic nanoparticles are used as an efficient carrier for drug molecules for developing novel drug delivery systems. In course of synthesizing these nanoparticles various chemicals, solvents and reagents are used which harms our eco system directly or indirectly. Silver nanoparticles (Ag NPs) have been widely used as a novel therapeutic agent extending its use as antibacterial, antifungal, anti-viral and anti-inflammatory agent. Silver nanoparticles (Ag NPs) prepared by green synthesis have many advantages over conventional methods involving chemical agents associated with environmental toxicity. Green synthetic methods include polysaccharide method, irradiation method, biological method, polyoxometallates method and tollens method. Green synthesis of nanoparticles is found to be an emerging branch of nanotechnology. The use of environmentally benign materials like plant leaf extract for the synthesis of nanoparticles offers numerous benefits of eco-friendliness and compatibility for pharmaceutical and biomedical applications as they do not use toxic chemicals in the synthesis protocols. Rapid and green synthetic methods using various plant extracts have shown a great potential in silver nanoparticles (Ag NPs) synthesis. This review article describes the bio-inspired synthesis of nanoparticles that provides advancement over chemical and physical methods as it is cost effective, eco-friendly and more effective in a variety of applications.

In the realm of cancer diagnostics, imaging and therapeutics, nanocarrier-based drug delivery systems have gained extensive importance owing to their promising attributes and potential to enhance therapeutic effectiveness. The primary area of research revolves around formulating innovative intelligent nanocarriers such as nanoparticles (NPs) which are capable of selectively responding to cancer-specific conditions and efficiently delivering medications to target cells. These nanocarriers, whether operating in a passive or active manner, can transport loaded therapeutic cargos to the tumor site while minimizing drug elimination from the drug delivery systems. This review primarily focuses on presenting recent advancements in the development and utilization of nanoparticles in the treatment of various cancer types, such as pancreatic cancer, prostate cancer, colorectal cancer, cervical cancer, and breast cancer.

Rheumatoid arthritis (RA) is a chronic condition causing joint pain and inflammation that has now spurred the interest in nanotechnology-based drug delivery for more effective treatment, and in this regard, carbon nanotubes (CNTs) are being explored for their potential to deliver the drugs steadily to manage the RA. Many investigators have been investigating both single-walled carbon nanotubes (SWCNT) as well as multi-walled carbon nanotubes (MWCNT) for managing arthritis via targeted drug delivery. Moreover, functionalized CNTs show promise in delivering the drugs precisely and in a controlled manner, thereby minimizing toxicity. However, research on applications of CNTs as drug carriers for RA remains limited, thus necessitating further exploration to address the various challenges. In this present piece of writing, challenges in RA treatment and the advances in applications of CNTs for RA management are reported, consequently reflecting the CNTs as advanced drug delivery vehicles for arthritis treatment.

Aptamers are single-stranded DNA or RNA molecules that exhibit remarkable affinity and specificity for a broad spectrum of biological targets, positioning them as compelling alternatives to antibodies in both diagnostics and therapeutics. Their ease of synthesis, chemical stability, and tunable binding properties make them highly adaptable for molecular recognition applications. Carbon Nanotubes (CNTs), on the other hand, are renowned for their unique structural, electrical, optical, and mechanical properties, ultimately providing an ideal nanoscale scaffold for aptamer conjugation. When combined with aptamers, CNTs form multifunctional hybrid nanoplatforms that merge the molecular selectivity of aptamers with the high surface area, conductivity, and mechanical strength of CNTs. This review discusses the fundamental concepts, functionalization strategies, and biomedical potential of aptamer-CNT hybrids. Both covalent and non-covalent conjugation approaches are examined, highlighting their impact on stability, sensitivity, and biocompatibility at the biointerface. Recent progress in molecular recognition, biosensing, targeted drug delivery, imaging, and theranostic applications is also summarized. Particular attention is given to the role of CNTs in enhancing electron transfer, signal amplification, and controlled therapeutic release. Moreover, diagnostic and therapeutic applications across various disease models, including cancer, infectious diseases, and neurodegenerative disorders, are highlighted. Furthermore, emerging challenges related to the toxicity, biodegradability, and pharmacokinetics of CNT-based hybrids are addressed, while considering regulatory and ethical perspectives that govern their clinical translation. Overall, aptamer-CNT hybrids hold immense promise as versatile, tunable, and multifunctional platforms that could fundamentally transform next-generation precision medicine and nanotherapeutic systems.